Search research articles
Contact Us
Filters
Showing results (1-10 of 85) with videos related to
Page
of 9
Sort By:
Pharmacogenomics
|
November 4, 2022
CYP2C18: the orphan in the CYP2C family
Pablo Zubiaur, Andrea Gaedigk
Pharmacogenomics
|
November 22, 2022
Use of pharmacogenetics for benzodiazepine prescription: state of the art and expectations
Pablo Zubiaur, Francisco Abad-Santos
Pharmaceutics
|
January 21, 2023
Association Studies in Clinical Pharmacogenetics
Pablo Zubiaur, Francisco Abad-Santos
Pharmacogenetics and Genomics
|
April 26, 2023
'Effect of CYP2C19 genetic variants on bleeding and major adverse cardiovascular events in a cohort of Arab patients undergoing percutaneous coronary intervention and stent implantation' by Ali et al. - reassess the evidence, shall we?
Miriam Saiz-Rodríguez, Pablo Zubiaur, Francisco Abad-Santos
Advances in Therapy
|
December 26, 2019
Author's Response to: 'Letter to the Editor in Response to: "Effect of Polymorphisms in CYP2C9 and CYP2C19 on the Disposition, Safety and Metabolism of Progesterone Administrated Orally or Vaginally"'
Pablo Zubiaur, Miriam Saiz-Rodríguez, Francisco Abad-Santos
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
November 13, 2022
"Pharmacogenetics of siponimod: A systematic review" by Díaz-Villamarín et al. - Information is power
Pablo Zubiaur, Miriam Saiz-Rodríguez, Francisco Abad-Santos
Clinical Pharmacology and Therapeutics
|
November 16, 2023
Response to "What is the Current Clinical Impact of the CYP2C:TG Haplotype?"
Pablo Zubiaur, J Steven Leeder, Francisco Abad-Santos, et al.
Clinical Pharmacokinetics
|
June 14, 2021
Influence of CYP2D6 Phenotypes on the Pharmacokinetics of Aripiprazole and Dehydro-Aripiprazole Using a Physiologically Based Pharmacokinetic Approach
Lisa Alina Kneller, Pablo Zubiaur, Dora Koller, et al.
Talanta
|
March 17, 2019
Simultaneous determination of six antipsychotics, two of their metabolites and caffeine in human plasma by LC-MS/MS using a phospholipid-removal microelution-solid phase extraction method for sample preparation
Dora Koller, Pablo Zubiaur, Miriam Saiz-Rodríguez, et al.
Pharmaceuticals (Basel, Switzerland)
|
April 26, 2025
Impact of Genetic Variation in Adrenergic Receptors on β-Blocker Effectiveness and Safety in Cardiovascular Disease Management: A Systematic Review
Houwaida Abbes, Paula Soria-Chacartegui, Asma Omezzine, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 85) with videos related to
Sort By:
Page
of 9
Pharmacogenomics
|
November 4, 2022
CYP2C18: the orphan in the CYP2C family
Pablo Zubiaur, Andrea Gaedigk
Pharmacogenomics
|
November 22, 2022
Use of pharmacogenetics for benzodiazepine prescription: state of the art and expectations
Pablo Zubiaur, Francisco Abad-Santos
Pharmaceutics
|
January 21, 2023
Association Studies in Clinical Pharmacogenetics
Pablo Zubiaur, Francisco Abad-Santos
Pharmacogenetics and Genomics
|
April 26, 2023
'Effect of CYP2C19 genetic variants on bleeding and major adverse cardiovascular events in a cohort of Arab patients undergoing percutaneous coronary intervention and stent implantation' by Ali et al. - reassess the evidence, shall we?
Miriam Saiz-Rodríguez, Pablo Zubiaur, Francisco Abad-Santos
Advances in Therapy
|
December 26, 2019
Author's Response to: 'Letter to the Editor in Response to: "Effect of Polymorphisms in CYP2C9 and CYP2C19 on the Disposition, Safety and Metabolism of Progesterone Administrated Orally or Vaginally"'
Pablo Zubiaur, Miriam Saiz-Rodríguez, Francisco Abad-Santos
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
November 13, 2022
"Pharmacogenetics of siponimod: A systematic review" by Díaz-Villamarín et al. - Information is power
Pablo Zubiaur, Miriam Saiz-Rodríguez, Francisco Abad-Santos
Clinical Pharmacology and Therapeutics
|
November 16, 2023
Response to "What is the Current Clinical Impact of the CYP2C:TG Haplotype?"
Pablo Zubiaur, J Steven Leeder, Francisco Abad-Santos, et al.
Clinical Pharmacokinetics
|
June 14, 2021
Influence of CYP2D6 Phenotypes on the Pharmacokinetics of Aripiprazole and Dehydro-Aripiprazole Using a Physiologically Based Pharmacokinetic Approach
Lisa Alina Kneller, Pablo Zubiaur, Dora Koller, et al.
Talanta
|
March 17, 2019
Simultaneous determination of six antipsychotics, two of their metabolites and caffeine in human plasma by LC-MS/MS using a phospholipid-removal microelution-solid phase extraction method for sample preparation
Dora Koller, Pablo Zubiaur, Miriam Saiz-Rodríguez, et al.
Pharmaceuticals (Basel, Switzerland)
|
April 26, 2025
Impact of Genetic Variation in Adrenergic Receptors on β-Blocker Effectiveness and Safety in Cardiovascular Disease Management: A Systematic Review
Houwaida Abbes, Paula Soria-Chacartegui, Asma Omezzine, et al.
Page
of 9